$54.04
00.00%
Pre-Market: Jul 19, 4:03 PM EDT
15 minutes delayed
Comments
Loading...
Halozyme Therapeutics
HALONASDAQ
Halozyme Therapeutics (HALO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Good
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Halozyme Therapeutics (NASDAQ:HALO) Stock Quotes, Forecast and News Summary
Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 1.24M |
| Day Range | - - - |
| 52 Wk Range | 32.83 - 55.82 |
| Market Cap | $6.88B |
| P/E Ratio | 22.42 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 64 |
| Short Interest | 9.59% |
| Days to Cover | 6.06 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Halozyme Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Halozyme Therapeutics (HALO) stock?
You can purchase shares of Halozyme Therapeutics (NASDAQ:HALO) through any online brokerage.
Who are Halozyme Therapeutics (HALO) competitors?
Other companies in Halozyme Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Halozyme Therapeutics (HALO) stock?
There is no analysis for Halozyme Therapeutics.
What is the forecast for Halozyme Therapeutics (HALO) stock?
Halozyme Therapeutics has a consensus price target of $54.71.
Current stock price for Halozyme Therapeutics (HALO)?
The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $54.04 last updated July 19, 2024 at 4:03 PM EDT.
Does Halozyme Therapeutics (HALO) pay a dividend?
There are no upcoming dividends for Halozyme Therapeutics.
When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?
Halozyme Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Halozyme Therapeutics (HALO) going to split?
There is no upcoming split for Halozyme Therapeutics.
What sector and industry does Halozyme Therapeutics (HALO) operate in?
Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.